{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:20:46Z","timestamp":1788283246868,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The patients with intermediate-high risk pulmonary embolism who have acute right ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise may be candidates for thrombolytic therapy. Alternative low-dose thrombolytic therapy strategies with prolonged infusion may further decrease the complication rates as its efficacy and safety have been previously proven in the management of prosthetic valve thrombosis. In this study, we aimed to investigate the clinical outcomes of low-dose prolonged thrombolytic therapy regimen in intermediate-high risk pulmonary embolism patients. This study enrolled 16 retrospectively evaluated patients (female 9, mean age: 70.9\u200a\u00b1\u200a13.5 years) with the diagnosis of acute pulmonary embolism who were treated with low-dose and slow-infusion of tissue-type plasminogen activator (t-PA). All patients underwent transthoracic echocardiography and computed tomography scan for assessment of thrombolytic therapy success. Low-dose prolonged thrombolytic therapy was successful in all patients. The mean t-PA dose used was 48.4\u200a\u00b1\u200a6.3\u200amg. There was residual segmental thrombus in nine (56.3%) patients after thrombolytic therapy. The arterial oxygen saturation and tricuspid annular plane systolic excursion increased after thrombolytic therapy whereas heart rate, RV to left ventricular (LV) ratio, systolic pulmonary artery pressure, and the frequencies of hypotension and tachypnea significantly decreased. There was no cerebrovascular accident or major bleeding requiring transfusion. There were two minor bleedings (12.5%) including hemoptysis and epistaxis. Thrombolytic therapy in these intermediate-high risk pulmonary embolism patients was associated with excellent clinical outcomes and survival to discharge (100%) without any 60-day mortality. Prolonged thrombolytic therapy regimen with low-dose and slow-infusion of t-PA may be associated with lower complication rates without comprimising effectiveness in patients with acute intermediate-high risk pulmonary embolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mbc.0000000000000960","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T08:01:33Z","timestamp":1605081693000},"page":"536-542","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism"],"prefix":"10.1097","volume":"31","author":[{"given":"Ahmet","family":"G\u00fcner","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macit","family":"Kal\u00e7ik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Hitit University, \u00c7orum"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet \u00c7.","family":"Aykan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sutcu Imam University, Kahramanmaras"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa O.","family":"G\u00fcrsoy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u0130zmir Katip \u00c7elebi University, Atat\u00fcrk Training and Reseach Hospital, \u0130zmir"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Kalkan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet A.","family":"Astarcio\u011flu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dumlupinar University, Kutahya Evliya Celebi Education and Research Hospital, Dumlupinar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ert\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi G.","family":"G\u00fcner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Health Sciences Turkey, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery and Research Hospital, Istanbul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ko\u015fuyolu Kartal Heart Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260901","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte","year":"2008","journal-title":"Circulation"},{"key":"R2-20260901","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-20260901","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"R4-20260901","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"4","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"(Suppl 2)","key":"R5-20260901","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease, antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians, Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"R6-20260901","article-title":"Low-dose alteplase for the treatment of submassive pulmonary embolism: a case series","author":"Layman","year":"2019","journal-title":"J Pharm Pract"},{"key":"R7-20260901","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MBC.0000000000000774","article-title":"Low-dose, short course alteplase treatment of submassive pulmonary embolism: a case series from the National Institutes of Health Clinical Center","volume":"29","author":"Lozier","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R8-20260901","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.15537\/smj.2018.11.22717","article-title":"Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism","volume":"39","author":"Zhang","year":"2018","journal-title":"Saudi Med J"},{"key":"R9-20260901","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11239-018-1686-2","article-title":"A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic","volume":"46","author":"Mahar","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"R10-20260901","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \u2018MOPETT\u2019 trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"Am J Cardiol"},{"key":"R11-20260901","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1378\/chest.09-0765","article-title":"Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial","volume":"137","author":"Wang","year":"2010","journal-title":"Chest"},{"key":"R12-20260901","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1076029618758953","article-title":"The efficacy and safety of intermittent low-dose urokinase thrombolysis for the treatment of senile acute intermediate-high-risk pulmonary embolism: a pilot trial","volume":"24","author":"Zhao","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"R13-20260901","first-page":"506","article-title":"Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: clinical efficacy but attendant hemorrhagic risks","volume":"93","author":"Rothschild","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R14-20260901","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"R15-20260901","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1570161115666170404122535","article-title":"Ultrasound-assisted catheter-directed thrombolysis in high-risk and intermediate-high-risk pulmonary embolism: a meta-analysis","volume":"16","author":"Kaymaz","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"R16-20260901","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/0003319716661446","article-title":"Ultrasound-assisted catheter-directed thrombolysis in high-risk and intermediate-high-risk pulmonary embolism: results from a single-center cohort","volume":"68","author":"Kaymaz","year":"2017","journal-title":"Angiology"},{"key":"R17-20260901","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"key":"R18-20260901","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R19-20260901","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4244\/EIJ-D-18-00371","article-title":"A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk","volume":"14","author":"Kaymaz","year":"2018","journal-title":"EuroIntervention"},{"key":"R20-20260901","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ajem.2016.06.026","article-title":"Thrombolysis in pulmonary embolism: full-dose, low-dose, or catheter-directed thrombolysis?","volume":"34","author":"Biteker","year":"2016","journal-title":"Am J Emerg Med"},{"key":"R21-20260901","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcmg.2012.10.016","article-title":"Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA Trial","volume":"6","author":"Ozkan","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"R22-20260901","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1076029615609698","article-title":"Prolonged infusions of low-dose thrombolytics in elderly patients with prosthetic heart valve thrombosis","volume":"23","author":"G\u00fcnd\u00fcz","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"R23-20260901","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"key":"R24-20260901","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"R26-20260901","doi-asserted-by":"crossref","first-page":"1801900","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Vonk Noordegraaf","year":"2019","journal-title":"Eur Respir J"},{"key":"R27-20260901","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","article-title":"Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations:an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R28-20260901","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1161\/01.CIR.0000147612.59751.4C","article-title":"Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism","volume":"110","author":"Schoepf","year":"2004","journal-title":"Circulation"},{"key":"R29-20260901","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11239-018-1710-6","article-title":"How to perform and manage low-dose and slow\/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis","volume":"46","author":"Guner","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"R30-20260901","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R31-20260901","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N Engl J Med"},{"key":"R32-20260901","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0033-1334145","article-title":"Thrombolytic therapy for acute pulmonary embolism","volume":"39","author":"Tapson","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"R33-20260901","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2015.11.061","article-title":"Management of pulmonary embolism: an update","volume":"67","author":"Konstantinides","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R34-20260901","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/clc.22216","article-title":"Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge","volume":"37","author":"Sharifi","year":"2014","journal-title":"Clin Cardiol"},{"key":"R35-20260901","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MBC.0b013e328359759c","article-title":"Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus","volume":"24","author":"Yildiz","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R36-20260901","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5152\/akd.2014.5273","article-title":"Successful treatment of a pulmonary embolism with low dose prolonged infusion of tissue typed plasminogen activator in a 37 year old female in early postoperative period","volume":"14","author":"Aykan","year":"2014","journal-title":"Anadolu Kardiyol Derg"},{"key":"R37-20260901","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R38-20260901","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0000000000000960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:02:50Z","timestamp":1788282170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0000000000000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000000960","relation":{},"ISSN":["0957-5235","1473-5733"],"issn-type":[{"value":"0957-5235","type":"print"},{"value":"1473-5733","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}